Several studies report that patients (including medicated patients) with MDD exhibit a decreased proportion and absolute number of classical CD16–CD14+ monocytes in peripheral blood compared to healthy controls (Nowak et al., 2019; Alvarez-Mon et al., 2021a,b). This evidence concerns the gene CD14 and major depressive disorder.